[Clinical studies with tablets combining lysozyme, papain and bacitracin]. 1967

M Dechaume, and P Laudenbach, and J Recoing

UI MeSH Term Description Entries
D008010 Lichen Planus An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a "saw-tooth" pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown. Cutaneous Lichen Planus,Lichen Planopilaris,Lichen Ruber Planus,Mucosal Lichen Planus,Lichen Rubra Planus,Lichen Planus, Cutaneous,Lichen Planus, Mucosal,Planopilaris, Lichen
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009059 Mouth Diseases Diseases involving the MOUTH. Disease, Mouth,Diseases, Mouth,Mouth Disease
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D010206 Papain A proteolytic enzyme obtained from Carica papaya. It is also the name used for a purified mixture of papain and CHYMOPAPAIN that is used as a topical enzymatic debriding agent. EC 3.4.22.2. Tromasin
D002613 Cheilitis Inflammation of the lips. It is of various etiologies and degrees of pathology. Cheilitides
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females

Related Publications

M Dechaume, and P Laudenbach, and J Recoing
March 1974, Indian journal of biochemistry & biophysics,
M Dechaume, and P Laudenbach, and J Recoing
March 1954, Arzneimittel-Forschung,
M Dechaume, and P Laudenbach, and J Recoing
May 1985, Indian journal of experimental biology,
M Dechaume, and P Laudenbach, and J Recoing
May 1963, Annals of the New York Academy of Sciences,
M Dechaume, and P Laudenbach, and J Recoing
December 1951, American journal of ophthalmology,
M Dechaume, and P Laudenbach, and J Recoing
November 1963, Semaine therapeutique,
M Dechaume, and P Laudenbach, and J Recoing
January 1969, Revista latinoamericana de microbiologia y parasitologia,
M Dechaume, and P Laudenbach, and J Recoing
January 2014, International archives of allergy and immunology,
M Dechaume, and P Laudenbach, and J Recoing
April 1995, The American journal of tropical medicine and hygiene,
M Dechaume, and P Laudenbach, and J Recoing
April 2012, Organic & biomolecular chemistry,
Copied contents to your clipboard!